Top Midday Stories: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks; Supreme Court Allows TikTok Ban to Take Effect

MT Newswires Live
01-18

Wall Street's major market averages were higher around midday Friday ahead of a long Martin Luther King, Jr. holiday weekend and the inauguration of President-elect Donald Trump.

In company news, Novo Nordisk (NVO) shares slid 4.8% after the Department of Health and Human Services said that the company's Ozempic, Wegovy and Rybelsus are among the 15 additional drugs selected for US Medicare price negotiations.

"Novo Nordisk remains opposed to government price setting through the [Inflation Reduction Act] and has significant concerns about how the law is being implemented by this administration," Novo Nordisk said in a statement emailed to MT Newswires.

The US Supreme Court will allow a ban on TikTok to take effect as scheduled on Sunday after rejecting an appeal on Friday.

Schlumberger (SLB) shares rose nearly 8% after it reported higher Q4 adjusted earnings and revenue and raised its quarterly dividend.

Truist Financial (TFC) shares climbed 4.8% after it reported higher Q4 adjusted earnings and total revenue.

Fastenal (FAST) shares added 2.3% after it said its Q4 net income was unchanged and net sales rose from a year earlier.

J.B. Hunt Transport Services (JBHT) shares retreated 6.9% in recent Friday trading after it reported Q4 earnings late Thursday of $1.53 per diluted share, which fell short of market expectations.

Price: 78.95, Change: -4.13, Percent Change: -4.97

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10